Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × IFL protocol × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 21 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 104 Cisplatin 28 lenvatinib 26 Paclitaxel 24 Carboplatin 24 Pemetrexed 13 Gemcitabine 9 Docetaxel 9 Saline Solution 8 Fluorouracil 8 Capecitabine 7 olaparib 6 Oxaliplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 epacadostat 5 Etoposide 5 Cetuximab 5 belzutifan 4 Leucovorin 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 enzalutamide 3 durvalumab 3 Glucose 3 Dexamethasone 3 Acetaminophen 3 trifluridine tipiracil drug combination 2 regorafenib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡